A Study of TAK-505 in Adults With Solid Tumors

ClinicalTrials.gov ID: NCT07436728

Public ClinicalTrials.gov record NCT07436728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 2:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 First-in-Human, Open-Label, Dose Escalation and Expansion Trial of TAK-505 Monotherapy in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Study identification

NCT ID: NCT07436728
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Takeda; Industry
Enrollment: 151 participants

Conditions and interventions

Conditions

Malignant Solid Tumors

Interventions

TAK-505 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 10, 2026
Primary completion: Aug 17, 2030
Completion: Aug 17, 2030
Last update posted: May 13, 2026

2026 – 2030

United States locations

U.S. sites: 15
U.S. states: 9
U.S. cities: 13

Facility	City	State	ZIP	Site status
UCI Health	Orange	California	92868	Not yet recruiting
University of California San Diego Medical Center, La Jolla	San Diego	California	92093	Not yet recruiting
University of California San Francisco	San Francisco	California	94143	Not yet recruiting
H Lee Moffitt Cancer Center	Tampa	Florida	33612	Not yet recruiting
Univeristy of Minnesota	Minneapolis	Minnesota	55455	Not yet recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Not yet recruiting
Cleveland Clinic Foundation	Cleveland	Ohio	44195	Not yet recruiting
Sarah Cannon Research Institute SCRI	Nashville	Tennessee	37203	Not yet recruiting
Tennessee Oncology	Nashville	Tennessee	37203	Not yet recruiting
Mary Crowley Cancer Center	Dallas	Texas	75230	Not yet recruiting
Baylor College of Medicine	Houston	Texas	77030	Not yet recruiting
MD Anderson	Houston	Texas	77030	Not yet recruiting
NEXT Oncology	San Antonio	Texas	78229	Recruiting
NEXT Oncology	Fairfax	Virginia	22031	Recruiting
Seattle Cancer Care Alliance	Seattle	Washington	98109	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07436728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 13, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07436728 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →